Advantage Alpha Capital Partners’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-14,122
Closed -$424K 6
2025
Q3
$424K Sell
14,122
-3,200
-18% -$90.2K 0.13% 107
2025
Q2
$496K Sell
17,322
-4,035
-19% -$120K 0.13% 100
2025
Q1
$705K Buy
21,357
+7,410
+53% +$242K 0.17% 93
2024
Q4
$401K Sell
13,947
-9,371
-40% -$269K 0.09% 138
2024
Q3
$653K Sell
23,318
-11,980
-34% -$319K 0.15% 96
2024
Q2
$851K Sell
35,298
-3,710
-10% -$91K 0.19% 90
2024
Q1
$1.06M Sell
39,008
-10,522
-21% -$299K 0.2% 100
2023
Q4
$1.37M Buy
+49,530
New +$1.29M 0.26% 93

Other funds holding ALKS

Advantage Alpha Capital Partners's ALKS Position: Q4 2025 in Review

Advantage Alpha Capital Partners sold out of Alkermes (ALKS) in Q4 2025, closing a stake of 14,122 shares — an estimated $424K sold.

Advantage Alpha Capital Partners first reported a position in ALKS in Q4 2023 and held it in 8 quarters. The position peaked at $1.37M in Q4 2023. 366 funds tracked by Wall St. Rank hold ALKS as of Q4 2025.

  • Advantage Alpha Capital Partners reported no remaining Alkermes position as of Q4 2025 after selling out during the quarter.
  • Advantage Alpha Capital Partners sold 14,122 Alkermes shares in Q4 2025, an estimated $424K.
  • Advantage Alpha Capital Partners first reported a position in Alkermes in Q4 2023 and held it in 8 quarters.
  • Advantage Alpha Capital Partners's Alkermes position peaked at $1.37M in Q4 2023.
  • 366 funds tracked by Wall St. Rank held Alkermes as of Q4 2025.

Based on Advantage Alpha Capital Partners's 13F filing for Q4 2025.